<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03140748</url>
  </required_header>
  <id_info>
    <org_study_id>PI2016_843_0036</org_study_id>
    <nct_id>NCT03140748</nct_id>
  </id_info>
  <brief_title>Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation</brief_title>
  <acronym>PERIGLUC1</acronym>
  <official_title>Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intraabdominal fungal infections with Candida are constantly increasing. Their diagnosis and
      treatment is difficult. Morbidity and mortality are high. Β-D-Glucan has been proposed as a
      marker of systemic fungal infection in candidemia. Moreover, its kinetics is associated with
      therapeutic success. On the other hand, there are no data on intraabdominal infections that
      are much more frequent. The objective of the study is to evaluate the initial levels of
      β-D-glucan and its daily kinetics during the treatment of fungal peritonitis in resuscitation
      compared to a control group with a yeast-free peritonitis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 6, 2017</start_date>
  <completion_date type="Anticipated">April 6, 2019</completion_date>
  <primary_completion_date type="Anticipated">April 6, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood determination of serum β-D-glucan kinetics in patients with peritonitis</measure>
    <time_frame>28 days</time_frame>
    <description>Blood determination of serum β-D-glucan kinetics in patients with peritonitis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Peritonitis Infectious</condition>
  <condition>Candida Infection</condition>
  <arm_group>
    <arm_group_label>Patients with fungal peritonitis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with peritonitis without yeast</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>To evaluate the initial levels and kinetics of serum β-D-glucan</intervention_name>
    <description>To evaluate the initial levels and kinetics of serum β-D-glucan during fungal peritonitis compared to a control group of yeast-free peritonitis</description>
    <arm_group_label>Patients with fungal peritonitis</arm_group_label>
    <arm_group_label>Patients with peritonitis without yeast</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Major Patient (age ≥ 18 years)

          -  Community or associated peritonitis, operated and hospitalized in resuscitation

          -  Affiliation to a social security scheme

        Exclusion Criteria:

          -  Allergy known to echinocandins

          -  Dying Patient

          -  Limitation of care

          -  Predictable duration of follow-up ≤ 10 days

          -  Transfusion within 3 months

          -  Patient minor, patient under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hervé DUPONT, PhD</last_name>
    <phone>+33322668375</phone>
    <email>dupont.herve@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens Picardie</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hervé DUPONT, p</last_name>
      <phone>+33322668375</phone>
      <email>dupont.herve@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2017</study_first_submitted>
  <study_first_submitted_qc>May 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2017</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peritonitis</mesh_term>
    <mesh_term>Candidiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

